SuperworthArtiva Biotherapeutics market cap ARTV
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $300.7M
- Highest close in our data
- $559.8M
- Aug 2026
Artiva Biotherapeutics is worth $300.7M at the close on Oct 23, 2026, at $6.15 a share.
That is up 128% over the last year.
Its highest close in our data was $559.8M in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $300.7M | $95.5M | $559.8M | +193% |
| 2025 | $102.6M | $35.8M | $259.2M | −60% |
| 2024 | $258.4M | $241.9M | $384.5M | n/a |
Against its peers
Companies in Biotechnology nearest Artiva Biotherapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| ARTVArtiva Biotherapeutics | $300.7M |
| PLXProtalix BioTherapeutics | $205.5M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Artiva Biotherapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.